RA Capital Management, L.P. 13D and 13G filings for POINT Biopharma Global Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-26 5:29 pm Sale | 2022-09-26 | 13D | POINT Biopharma Global Inc. PNT | RA Capital Management, L.P. | 0 0.000% | -9,003,018 (Position Closed) | Filing |
| 2022-09-16 4:29 pm Unchanged | 2022-09-14 | 13D | POINT Biopharma Global Inc. PNT | RA Capital Management, L.P. | 9,003,018 8.650% | 0 (Unchanged) | Filing |
| 2022-08-29 5:01 pm Purchase | 2022-08-25 | 13D | POINT Biopharma Global Inc. PNT | RA Capital Management, L.P. | 9,003,018 9.900% | 147,000 (+1.66%) | Filing |
| 2021-09-14 4:30 pm Unchanged | 2009-02-28 | 13D | POINT Biopharma Global Inc. PNT | RA Capital Management, L.P. | 8,856,018 9.800% | 0 (Unchanged) | Filing |
| 2021-07-20 4:31 pm Purchase | 2021-07-20 | 13G | POINT Biopharma Global Inc. PNT | RA Capital Management, L.P. | 8,856,018 9.800% | 8,856,018 (New Position) | Filing |